Medifast ( NYSE:MED ) Full Year 2024 Results Key Financial Results Revenue: US$602.5m (down 44% from FY 2023). Net... Medifast's Q2 results show challenges related to weak customer acquisition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback